top of page
Image-empty-state_edited.jpg

Cytonics

Favorite-Icon-p-1600.png
Favorite-Icon-p-1600_filled.png
Login to favorite a company
Developing diagnostics and therapeutics for osteoarthritis
Most Recent Valuation:

$65,790,000.00

Legal Name:
Founded:
State of HQ:

Cytonics Corp

2006

FL

Company Description

Employees:

[]

Funding Summary

Number of funding rounds
4
Total amount raised
$11,214,290
Round name
End date
Raised
Status
Type
Investment minimum
Valuation
Valuation Cap
Price per share
Cytonics Preferred Stock 4
05/29/2024
$3,705,913.52
closed
Preferred Stock
$499
$65,790,000
2.3
Cytonics Corporation Preferred Stock 2
10/14/2022
$2,848,738.00
closed
Preferred Stock
$1,001
$58,915,996
Cytonics Corporation Stock 2
04/30/2021
$4,659,638.00
closed
Preferred Stock
$1,000
$46,190,000
2
Cytonics Corporation Share 1
closed
Screen Shot 2020-07-15 at 12.01.28 PM.pn

See round history

Round history

Round name
Perk description
Perk level (dollars)
Perk level (days)
Loading...

Early Bird Perk history

Screen Shot 2020-07-15 at 12.01.28 PM.pn

View early bird perks, deal notes, company financials, and more

Company notes

Type
Round name
Date Added
Date Updated
Notes
Loading...

Financials (up to prior 4 years)

Revenue
COGS
Gross margin | (%)
Taxes
SG&A, other
Net income
Cash/Equivalents
Accounts Receiv
Other Assets
Assets
Short term debt
Long term debt
Equity/other liabilities

Gross margin, Other Assets, and Equity/other liabilities are derived from the financial statements of the company reported to the SEC. Assets = Liabilities + Equity, and no equity accounts nor accounts payable are reported to the SEC, hence the possibility for that amount to be either equity or a liability.

bottom of page